Cost-Effectiveness Analysis of Abiraterone, Docetaxel or Placebo Plus Androgen Deprivation Therapy for Hormone-Sensitive Advanced Prostate Cancer

Einstein (São Paulo, Brazil) - Brazil
doi 10.31744/einstein_journal/2019gs4414
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein

Related search

Abiraterone Acetate and Docetaxel With Androgen Deprivation Therapy in High-Volume Metastatic Hormone-Sensitive Prostate Cancer in China: An Indirect Treatment Comparison and Cost Analysis

Cost Effectiveness and Resource Allocation
Health Policy
2019English

Comparative Effectiveness of Radical Prostatectomy With Adjuvant Radiotherapy Versus Radiotherapy Plus Androgen Deprivation Therapy for Men With Advanced Prostate Cancer

Cancer
Cancer ResearchOncology
2018English

Androgen Deprivation Therapy for Prostate Cancer

2017English

Cost-Effectiveness of Metastasis-Directed Therapy in Oligorecurrent Hormone-Sensitive Prostate Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2019English

Decision Analytic Cost-Effectiveness Model to Compare Prostate Cryotherapy to Androgen Deprivation Therapy for Treatment of Radiation Recurrent Prostate Cancer

BMJ Open
Medicine
2015English

Medical Resource Utilization of Abiraterone Acetate Plus Prednisone Added to Androgen Deprivation Therapy in Metastatic Castration-Naive Prostate Cancer: Results From LATITUDE

Cancer
Cancer ResearchOncology
2018English

Androgen Deprivation Therapy for Prostate Cancer and Risk of Dementia

BJU International
Urology
2019English

Role of Androgen Deprivation Therapy for Node-Positive Prostate Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2009English

Re: Androgen Deprivation With or Without Radiation Therapy for Clinically Node-Positive Prostate Cancer

European Urology
Urology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy